Back to Trades
Sell4
Travere Therapeutics, Inc.
TVTX
Total Value
$1.4M
Net $902.6K sold
Sales
$902.6K
1 transaction
Company Information
- Company Name
- Travere Therapeutics, Inc.
- Ticker Symbol
- TVTX
- CIK
- 0001438533
Insider Information
- Name
- Calvin Sandra
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Apr 16, 2026
- Transaction Date
- Apr 14, 2026
- Accession Number
- 0001882909-26-000003
- Form Type
- 4
- Net Trading Amount
- -$902.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 14, 2026 | Common Stock | 2,500 | $22.40 | Exercise | $56.0K |
| Apr 14, 2026 | Common Stock | 6,250 | $8.93 | Exercise | $55.8K |
| Apr 14, 2026 | Common Stock | 6,500 | $20.46 | Exercise | $133.0K |
| Apr 14, 2026 | Common Stock | 21,977 | $41.07 | Sale | $902.6K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 14, 2026 | Derivative | 2,500 | $22.40 | Exercise | $56.0K |
| Apr 14, 2026 | Derivative | 6,250 | $8.93 | Exercise | $55.8K |
| Apr 14, 2026 | Derivative | 6,500 | $20.46 | Exercise | $133.0K |
Footnotes
- (F1)This sale was made pursuant to a written plan adopted on June 10, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
- (F2)One-fourth of the shares subject to the stock option vested and became exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.
- (F3)One-fourth of the shares subject to the stock option vested and became exercisable on the first anniversary of January 31, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.
- (F4)One-fourth of the shares subject to the stock option vested and become exercisable on the first anniversary of January 31, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.